Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M107,315Revenue (TTM) $M12,191Net Margin (%)21.4Altman Z-Score4.7
Enterprise Value $M111,458EPS (TTM) $3.2Operating Margin %30.8Piotroski F-Score5
P/E(ttm)42.6Beneish M-Score-2.6Pre-tax Margin (%)23.9Higher ROA y-yN
Price/Book12.710-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsY
Price/Sales9.15-y EBITDA Growth Rate %16.1Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow26.5y-y EBITDA Growth Rate %17.4ROA % (ttm)9.3Higher Current Ratio y-yN
Dividend Yield %--PEG2.7ROE % (ttm)38.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M782ROIC % (ttm)25.5Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

CELG is held by these investors:

CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Curran TerrieSee remarks 2017-09-25Sell1,727$143.89-3.5view
KAPLAN GILLADirector 2017-09-12Sell9,250$141.56-1.91view
CASEY MICHAEL DDirector 2017-09-05Sell9,250$139.03-0.12view
MARIO ERNESTDirector 2017-08-10Sell18,506$130.526.39view
KAPLAN GILLADirector 2017-08-02Sell7,500$134.523.23view
LOUGHLIN JAMES JDirector 2017-06-26Sell18,500$133.573.96view
Friedman Michael ADirector 2017-06-22Sell10,000$132.54.8view
HUGIN ROBERT Jsee remarks 2017-06-22Sell175,970$134.143.52view
CASEY MICHAEL DDirector 2017-06-21Sell9,250$133.054.37view
Friedman Michael ADirector 2017-06-19Sell5,000$12511.09view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
Strategic Research Analysis ­ Positioning to Benefit on  Abbott, Rite Aid, Kroger, Celgene, Tw Oct 10 2017 
Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Opening Bell Sep 06 2017 
InvestorsObserver releases covered-call reports for Amazon.com, Bristol-Myers Squibb, Celgene, PayPa Jul 27 2017 
Spiros Segalas Commentary on Celgene Jul 10 2017 
Spiros Segalas' Harbor Capital Appreciation Fund Managers' Commentary Jul 10 2017 
David Rolfe Gains 3 Holdings, Sells 2 Others in 1st Quarter May 16 2017 
Study These Gurus, but Don’t Buy Their Funds Apr 14 2017 
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary Feb 14 2017 
Celgene Switzerland Invests in Jounce Therapeutics Feb 02 2017 
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary Jan 24 2017 

More From Our Partners
Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks Oct 17 2017 - ZACKS
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat